iodoacetamide has been researched along with Lymphoma, Non-Hodgkin in 1 studies
Lymphoma, Non-Hodgkin: Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hansen, HP | 1 |
| Kisseleva, T | 1 |
| Kobarg, J | 1 |
| Horn-Lohrens, O | 1 |
| Havsteen, B | 1 |
| Lemke, H | 1 |
1 other study available for iodoacetamide and Lymphoma, Non-Hodgkin
| Article | Year |
|---|---|
A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines.
Topics: Antibodies, Monoclonal; Calcimycin; Down-Regulation; Glycosylation; Hodgkin Disease; Humans; Iodoace | 1995 |